1. Home
  2. AMTD vs CNTX Comparison

AMTD vs CNTX Comparison

Compare AMTD & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMTD
  • CNTX
  • Stock Information
  • Founded
  • AMTD 2003
  • CNTX 2015
  • Country
  • AMTD France
  • CNTX United States
  • Employees
  • AMTD N/A
  • CNTX N/A
  • Industry
  • AMTD
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMTD
  • CNTX Health Care
  • Exchange
  • AMTD Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • AMTD 77.3M
  • CNTX 76.5M
  • IPO Year
  • AMTD 2019
  • CNTX 2021
  • Fundamental
  • Price
  • AMTD $1.12
  • CNTX $1.15
  • Analyst Decision
  • AMTD
  • CNTX Strong Buy
  • Analyst Count
  • AMTD 0
  • CNTX 4
  • Target Price
  • AMTD N/A
  • CNTX $7.38
  • AVG Volume (30 Days)
  • AMTD 23.3K
  • CNTX 958.7K
  • Earning Date
  • AMTD 01-03-2025
  • CNTX 11-06-2024
  • Dividend Yield
  • AMTD N/A
  • CNTX N/A
  • EPS Growth
  • AMTD N/A
  • CNTX N/A
  • EPS
  • AMTD 2.37
  • CNTX N/A
  • Revenue
  • AMTD $122,715,000.00
  • CNTX N/A
  • Revenue This Year
  • AMTD N/A
  • CNTX N/A
  • Revenue Next Year
  • AMTD N/A
  • CNTX N/A
  • P/E Ratio
  • AMTD $0.48
  • CNTX N/A
  • Revenue Growth
  • AMTD N/A
  • CNTX N/A
  • 52 Week Low
  • AMTD $1.06
  • CNTX $0.89
  • 52 Week High
  • AMTD $2.00
  • CNTX $2.75
  • Technical
  • Relative Strength Index (RSI)
  • AMTD 41.56
  • CNTX 32.32
  • Support Level
  • AMTD $1.11
  • CNTX $0.94
  • Resistance Level
  • AMTD $1.16
  • CNTX $1.61
  • Average True Range (ATR)
  • AMTD 0.06
  • CNTX 0.14
  • MACD
  • AMTD -0.00
  • CNTX -0.01
  • Stochastic Oscillator
  • AMTD 28.85
  • CNTX 29.75

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: